Announce Date | 03/27/2025 |
EPS Normalized Actual | $0.19 (Beat by $0.02) |
EPS GAAP Actual | $0.19 (Beat by $0.02) |
Revenue Actual | $0.008083B |
Revenue Surprise | Beat by $8.083M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.26 |
EPS GAAP Estimate | $0.26 |
Revenue Estimate | $0.0099B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.02 | 9.75 | 1.02 | 1.02 | 1 |
Dec 2028 | 0.77 | 12.91 | 0.76315 | 0.77685 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.16 | -0.01 | 0.008083B | -20.8% | -1.14M |
FQ3 2024 (Sep 2024) | -0.16 | -0.31 | 0.009416B | 1.54% | 0.58M |
FQ2 2024 (Jun 2024) | 0.15 | -1.19259 | 0.00868B | -3.57% | -9.3M |
FQ1 2024 (Mar 2024) | 0.12 | 0.12 | 0.008419B | -17.08% | 8.42M |
FQ4 2023 (Dec 2023) | 0.0012 | 0.0012 | 0.009764B | -121.13% | 9.76M |
FQ3 2023 (Sep 2023) | 0.12 | 0.12 | 0.009271B | -0.97% | 9.27M |
FQ2 2023 (Jun 2023) | 0.15 | 0.15 | 0.00899B | -3.31% | 8.99M |
FQ1 2023 (Mar 2023) | 0.17 | 0.17 | 0.009857B | 100% | 9.86M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.26
Consensus Revenue Estimates
0.0099B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.24 | -- | 0.24 | 0.24 | 1 |
FQ3 2026 (Sep 2026) | 0.25 | -- | 0.25 | 0.25 | 1 |
FQ2 2026 (Jun 2026) | 0.2 | -- | 0.2 | 0.2 | 1 |
FQ1 2026 (Mar 2026) | 0.19 | -- | 0.19 | 0.19 | 1 |
FQ4 2025 (Oct 2025) | 0.17 | 5.88 | 0.16747 | 0.17246 | 0 |
FQ3 2025 (Jul 2025) | 0.15 | 206.67 | 0.14776 | 0.15217 | 0 |
FQ2 2025 (Jun 2025) | 0.26 | 42.31 | 0.26 | 0.26 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ3 2026 (Sep 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ2 2026 (Jun 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ1 2026 (Mar 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ4 2025 (Oct 2025) | 0.01B | 16.67 | 0.01B | 0.01B | 0 |
FQ3 2025 (Jul 2025) | 0.01B | 0.88 | 0.01B | 0.01B | 0 |
FQ2 2025 (Jun 2025) | 0.01B | 12.32 | 0.01B | 0.01B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.17 | 0.16 | -0.01 | -6.25% |
FQ3 2024 (Sep 2024) | 0.15 | -0.16 | -0.31 | 193.75% |
FQ2 2024 (Jun 2024) | 1.34259 | 0.15 | -1.19259 | -795.06% |
FQ1 2024 (Mar 2024) | 0.12 | 0.12 | 100% | |
FQ4 2023 (Dec 2023) | 0.0012 | 0.0012 | 100% | |
FQ3 2023 (Sep 2023) | 0.12 | 0.12 | 100% | |
FQ2 2023 (Jun 2023) | 0.15 | 0.15 | 100% | |
FQ1 2023 (Mar 2023) | 0.17 | 0.17 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0.01B | $0.01B | $-1.14M | -14.05% |
FQ3 2024 (Sep 2024) | $0.01B | $0.01B | $0.58M | 6.16% |
FQ2 2024 (Jun 2024) | $0.02B | $0.01B | $-9.3M | -107.14% |
FQ1 2024 (Mar 2024) | $0B | $0.01B | $8.42M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.01B | $9.76M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.01B | $9.27M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.01B | $8.99M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.01B | $9.86M | 100% |